Special Issue "Applications of Mesoporous Silica Nanoparticles (MSNs) in Innovative Drug Delivery and Therapeutics"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 1468
Special Issue Editors
Interests: mesoporous silica nanoparticles; pharmaceutical ionic liquids (API-ILs); drug delivery; photochromic and electrochromic devices; catalysis
Interests: active pharmaceutical ingredients as organic salts and ionic liquids; API-OSILs; bioavailability; drug delivery; ionic liquids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mesoporous silica nanoparticles (MSNs) offer several advantages in drug formulations. On one hand, they can act as antimicrobial agents by themselves, with specific activity according to their structure. On the other hand, they can also increase the therapeutic effect of drugs, either by targeted delivery to the disease site or by controlled drug release. In the latter case, nonspecific interactions are minimized, thus lowering side effects and decreasing the required treatment dose. In addition, these nanomaterials have tailored mesoporous structures, large surface area and pore volume, selective surface functionality, morphology control, high loading capacity for therapeutic agents and good biocompatibility.
In this Special Issue, we invite academics and pharmaceutical researchers to bring their new insights into innovative MSN-based methods to improve therapeutic efficacy and controlled drug delivery, among other pharmaceutical applications.
Dr. Sandra Gago
Dr. Miguel Santos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- controlled drug release
- drug delivery
- mesoporous silica nanoparticles
- MSNs
- nanomedicine
